196 related articles for article (PubMed ID: 22761298)
1. Lipopolysaccharide heterogeneity in the atypical group of novel emerging Brucella species.
Zygmunt MS; Jacques I; Bernardet N; Cloeckaert A
Clin Vaccine Immunol; 2012 Sep; 19(9):1370-3. PubMed ID: 22761298
[TBL] [Abstract][Full Text] [Related]
2. O-Polysaccharide epitopic heterogeneity at the surface of Brucella spp. studied by enzyme-linked immunosorbent assay and flow cytometry.
Cloeckaert A; Weynants V; Godfroid J; Verger JM; Grayon M; Zygmunt MS
Clin Diagn Lab Immunol; 1998 Nov; 5(6):862-70. PubMed ID: 9801349
[TBL] [Abstract][Full Text] [Related]
3. A
Soler-Lloréns PF; Quance CR; Lawhon SD; Stuber TP; Edwards JF; Ficht TA; Robbe-Austerman S; O'Callaghan D; Keriel A
Front Cell Infect Microbiol; 2016; 6():116. PubMed ID: 27734009
[No Abstract] [Full Text] [Related]
4. Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry.
Bowden RA; Cloeckaert A; Zygmunt MS; Bernard S; Dubray G
Infect Immun; 1995 Oct; 63(10):3945-52. PubMed ID: 7558303
[TBL] [Abstract][Full Text] [Related]
5. Characterization of O-polysaccharide specific monoclonal antibodies derived from mice infected with the rough Brucella melitensis strain B115.
Cloeckaert A; Zygmunt MS; Dubray G; Limet JN
J Gen Microbiol; 1993 Jul; 139(7):1551-6. PubMed ID: 7690392
[TBL] [Abstract][Full Text] [Related]
6. The new strains Brucella inopinata BO1 and Brucella species 83-210 behave biologically like classic infectious Brucella species and cause death in murine models of infection.
Jiménez de Bagüés MP; Iturralde M; Arias MA; Pardo J; Cloeckaert A; Zygmunt MS
J Infect Dis; 2014 Aug; 210(3):467-72. PubMed ID: 24558120
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomics of early-diverging Brucella strains reveals a novel lipopolysaccharide biosynthesis pathway.
Wattam AR; Inzana TJ; Williams KP; Mane SP; Shukla M; Almeida NF; Dickerman AW; Mason S; Moriyón I; O'Callaghan D; Whatmore AM; Sobral BW; Tiller RV; Hoffmaster AR; Frace MA; De Castro C; Molinaro A; Boyle SM; De BK; Setubal JC
mBio; 2012; 3(5):e00246-12. PubMed ID: 22930339
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical identification of Brucella abortus lipopolysaccharide epitopes.
Rojas N; Freer E; Weintraub A; Ramirez M; Lind S; Moreno E
Clin Diagn Lab Immunol; 1994 Mar; 1(2):206-13. PubMed ID: 7496947
[TBL] [Abstract][Full Text] [Related]
9. Identification of an unusual Brucella strain (BO2) from a lung biopsy in a 52 year-old patient with chronic destructive pneumonia.
Tiller RV; Gee JE; Lonsway DR; Gribble S; Bell SC; Jennison AV; Bates J; Coulter C; Hoffmaster AR; De BK
BMC Microbiol; 2010 Jan; 10():23. PubMed ID: 20105296
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide heterogeneity in Brucella strains isolated from marine mammals.
Baucheron S; Grayon M; Zygmunt MS; Cloeckaert A
Res Microbiol; 2002 Jun; 153(5):277-80. PubMed ID: 12160318
[TBL] [Abstract][Full Text] [Related]
11. Brucella inopinata sp. nov., isolated from a breast implant infection.
Scholz HC; Nöckler K; Göllner C; Bahn P; Vergnaud G; Tomaso H; Al Dahouk S; Kämpfer P; Cloeckaert A; Maquart M; Zygmunt MS; Whatmore AM; Pfeffer M; Huber B; Busse HJ; De BK
Int J Syst Evol Microbiol; 2010 Apr; 60(Pt 4):801-808. PubMed ID: 19661515
[TBL] [Abstract][Full Text] [Related]
12. O-chain expression in the rough Brucella melitensis strain B115: induction of O-polysaccharide-specific monoclonal antibodies and intracellular localization demonstrated by immunoelectron microscopy.
Cloeckaert A; Zygmunt MS; Nicolle JC; Dubray G; Limet JN
J Gen Microbiol; 1992 Jun; 138(6):1211-9. PubMed ID: 1382111
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model.
Monreal D; Grilló MJ; González D; Marín CM; De Miguel MJ; López-Goñi I; Blasco JM; Cloeckaert A; Moriyón I
Infect Immun; 2003 Jun; 71(6):3261-71. PubMed ID: 12761107
[TBL] [Abstract][Full Text] [Related]
14. Selection of phage-displayed peptides recognised by monoclonal antibodies directed against the lipopolysaccharide of Brucella.
Mertens P; Walgraffe D; Laurent T; Deschrevel N; Letesson JJ; De Bolle X
Int Rev Immunol; 2001; 20(2):181-99. PubMed ID: 11878764
[TBL] [Abstract][Full Text] [Related]
15. The epitopic and structural characterization of Brucella suis biovar 2 O-polysaccharide demonstrates the existence of a new M-negative C-negative smooth Brucella serovar.
Zaccheus MV; Ali T; Cloeckaert A; Zygmunt MS; Weintraub A; Iriarte M; Moriyón I; Widmalm G
PLoS One; 2013; 8(1):e53941. PubMed ID: 23335981
[TBL] [Abstract][Full Text] [Related]
16. Outer-membrane protein- and rough lipopolysaccharide-specific monoclonal antibodies protect mice against Brucella ovis.
Bowden RA; Cloeckaert A; Zygmunt MS; Dubray G
J Med Microbiol; 1995 Nov; 43(5):344-7. PubMed ID: 7562998
[TBL] [Abstract][Full Text] [Related]
17. Comparative genomics of early-diverging Brucella strains reveals a novel lipopolysaccharide biosynthesis pathway.
Wattam AR; Inzana TJ; Williams KP; Mane SP; Shukla M; Almeida NF; Dickerman AW; Mason S; Moriyón I; O'Callaghan D; Whatmore AM; Sobral BW; Tiller RV; Hoffmaster AR; Frace MA; De Castro C; Molinaro A; Boyle SM; De BK; Setubal JC
mBio; 2012 Nov; 3(5):e00246-11. PubMed ID: 23131829
[TBL] [Abstract][Full Text] [Related]
18. Characterization of smooth Brucella lipopolysaccharides and polysaccharides by monoclonal antibodies.
Vizcaino N; Chordi A; Fernández-Lago L
Res Microbiol; 1991; 142(9):971-8. PubMed ID: 1805311
[TBL] [Abstract][Full Text] [Related]
19. Brucella melitensis cell envelope protein and lipopolysaccharide epitopes involved in humoral immune responses of naturally and experimentally infected sheep.
Zygmunt MS; Cloeckaert A; Dubray G
J Clin Microbiol; 1994 Oct; 32(10):2514-22. PubMed ID: 7529242
[TBL] [Abstract][Full Text] [Related]
20. Use of western immunoblot analysis for testing moose serum for Brucella suis biovar 4 specific antibodies.
Edmonds MD; Ward FM; O'Hara TM; Elzer PH
J Wildl Dis; 1999 Jul; 35(3):591-5. PubMed ID: 10479098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
